Organ-on-a-Chip & Tissue-on-a-Chip Europe 2018 focuses on an important and expanding field wherein cells are being assembled using Microfluidics and Lab-on-a-Chip technologies in a functionally-relevant manner. These clusters of "assembled cells" have functional significance and can mimic in vivo organ structure.
Liver cells assembled on-board chips in a physiologically-relevant architecture using microfluidics can, for instance, be utilized for toxicity screening and the ability to assemble organ fragments ex vivo can provide an exquisite means to reconstruct biological processes (both physiological and pathological) "in a dish" or "on a chip." A number of chips such Lung-on-a-Chip, Brain-on-a-Chip, Gut-on-a-Chip, Marrow-on-a-Chip, Bone-on-a-Chip, Nerve-on-a-Chip amongst others have been built and will be presented and explored at this conference. We will also focus on "disease-on-a-chip", cancer-on-a-chip, immune system-on-a-chip.
Due to the Overlap of this Topic with Microfluidics and Lab-on-a-Chip technologies, the co-located concurrent parallel conference track focus on these topics thereby offering complete coverage of these related fields to the conference delegates.
The Conference Tracks are Co-Located and Concurrent and Delegates can Participate, Mix-and-Match Presentations and Network Extensively with their Colleagues from all Conference Tracks. The Exhibit hall is also co-located and accessible by delegates from all three conference tracks.
All the Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.
The venue in Rotterdam offers unparalleled access from across Europe and around-the-world.
*Please note: events may be cancelled due to commercial or organisational reasons. In this case Research and Markets will refund all registration fees which have already been paid. Research and Markets will not refund any charges arising from the participant having to cancel or re-book transportation or accommodation which he or she has arranged.
- 3D-Printing of Microfluidics Structures and Other Biologically-Active Structures
- Artery-on-a-Chip for Cardiovascular Disease Research
- Hematological Systems-on-a-Chip, Platelets-on-a-Chip
- Liver-on-a-Chip for Toxicity Screening/Toxicology Studies
- Microfluidics/Lab-on-a-Chip (LOAC) Technologies for Constructing Organ-on-a-Chip/Tissue-on-a-Chip/Body-on-a-Chip
- Modeling Disease-on-a-Chip: Cancer-on-a-Chip, Immune System-on-a-Chip, Thrombosis-on-a-Chip
- Organ-on-a-Chip Applications for Drug Discovery
Keough-Hesburgh Professor of Electrical Engineering & Systems Biology, The University of Notre Dame
Professor and Director, Collaborative Research Center for Bio/Nano Hybrid Process, Institute of Industrial Science, The University of Tokyo
R. Eugene and Susie E. Goodson Professor of Biomedical Engineering, Duke University
Professor of Analytical Chemistry and Pharmaceutical Analysis, University of Groningen
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, The University of Kansas
Andries D. van der Meer
Tenure Track Assistant Professor, University of Twente
Professor of Biomedical Sensors Engineering, Vice Chair Department of Bioengineering, Imperial College London
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)
Noo Li Jeon
Professor, Seoul National University
Head, Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research, University of Bern-Switzerland
Associate Professor, Faculty of Mechanical Engineering; Head, Technion Microfluidic Technologies Laboratory, Technion, Israel Institute of Technology
Professor, Okinawa Institute of Science and Technology
Geraldine A Hamilton
President/Chief Scientific Officer, Emulate Inc
Drug Metabolism and Pharmacokinetics, Cardiovascular and Metabolic Diseases, AstraZeneca, Gothenburg
Associate Director For Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)
Confirmed Speakers to Date
Chief Scientific Officer, Microfluidic ChipShop GmbH
Director at Translational Center of Tissue Chip Technologies, Massachusetts Institute of Technology (MIT)
Senior Scientist, AstraZeneca
Researcher, Future Industries Institute, University of South Australia
Scientist, Mechanistic Safety, Pharmaceutical Sciences, Roche Pharmaceutical Research and Early Development
Assistant Professor, Department of Physiology and Pharmacology, Karolinska Institute
Professor, University of Twente
Professor and Chair of Neurobiological Psychiatry, Erasmus University Medical Center
Assistant Professor for Experimental Regenerative Medicine, Faculty of Medicine, Eberhard Karls University Tübingen
Senior Scientist, TissUse GmbH
Associate Professor of Biomedical Engineering; Co-founder and CSO, AxoSim Technologies, Tulane University
Researcher, Institute of Microelectronics of Barcelona
Senior Lecturer, Institute for Frontier Life and Medical Sciences, Kyoto University
3012 CC Rotterdam,